You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 156 No. 21, 25 NOVEMBER 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (53)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Antibodies to Bartonella Species in Inner-city Intravenous Drug Users in Baltimore, Md

James A. Comer, PhD; Colin Flynn, ScM; Russell L. Regnery, PhD; David Vlahov, PhD; James E. Childs, ScD

Arch Intern Med. 1996;156(21):2491-2495.


Abstract



Background
Bartonella quintana has recently been associated with homeless alcoholic men. Both B quintana and Bartonella henselae have been shown to be opportunistic pathogens of people with acquired immunodeficiency syndrome. The reservoirs and modes of transmission of these infections are incompletely known.

Objectives
To examine serum samples that were taken from inner-city intravenous (IV) drug users for antibodies to Bartonella organisms to determine whether there is an urban transmission cycle for Bartonella species and to examine the demographic and behavioral characteristics of IV drug users to identify possible risk factors for infection with any of these agents.

Materials and Methods
A serologic survey was conducted, using a convenience sample of serum specimens collected during a study of IV drug use and human immunodeficiency virus infection among 630 inner-city residents in Baltimore, Md. A detailed questionnaire was administered at the initial collection of serum, and additional serum collections and questionnaire updates were made at 6-month intervals. The most recent available serum sample was tested for Bartonella antibody titer by using the indirect immunofluorescent antibody test with 3 antigens: Bartonella elizabethae, B henselae, and B quintana. Univariate and multivariate analyses of selected potential demographic and behavioral risk factors were conducted.

Results
Antibodies to Bartonella were highly prevalent in this group; more than 37% of all samples reacted with at least 1 antigen. Overall seroprevalence of antibodies to B elizabethae, B henselae, and B quintana was 33%, 11%, and 10%, respectively. Current IV drug use, frequency of injection, and seronegative human immunodeficiency virus status were significantly associated with Bartonella antibody presence, but these associations varied by analysis. There was a significant inverse association of antibody prevalence to B henselae and B quintana by using CD4+ cell counts among human immunodeficiency virus—seropositive individuals.

Conclusions
Intravenous drug users have an elevated prevalence of antibodies to Bartonella organisms and may be at significant risk of becoming infected. Current IV drug use, high frequency of injection, and seronegative human immunodeficiency virus status are significant risk factors for an increased prevalence of Bartonella antibodies. The current natural histories of Bartonella species are rapidly changing, and mechanisms of transmission remain unknown.

Arch Intern Med. 1996;156:2491-2495



Author Affiliations



From the Viral and Rickettsial Zoonoses Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga (Drs Comer, Regnery, and Childs), and the Infectious Diseases Program, Department of Epidemiology, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Md (Mr Flynn and Dr Vlahov).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

MOLECULAR DETECTION OF RICKETTSIA FELIS, RICKETTSIA TYPHI AND TWO GENOTYPES CLOSELY RELATED TO BARTONELLA ELIZABETHAE.
DE SOUSA et al.
Am J Trop Med Hyg 2006;75:727-731.
ABSTRACT | FULL TEXT  

Randomized Open Trial of Gentamicin and Doxycycline for Eradication of Bartonella quintana from Blood in Patients with Chronic Bacteremia
Foucault et al.
Antimicrob. Agents Chemother. 2003;47:2204-2207.
ABSTRACT | FULL TEXT  

Prevalence Study of Antibody to Ratborne Pathogens and Other Agents among Patients Using a Free Clinic in Downtown Los Angeles
Smith et al.
The Journal of Infectious Disease 2002;186:1673-1676.
ABSTRACT | FULL TEXT  

Bartonella quintana Bacteremia among Homeless People
Foucault et al.
Clinical Infectious Diseases 2002;35:684-689.
ABSTRACT | FULL TEXT  

Natural History of Bartonella Infections (an Exception to Koch's Postulate)
Jacomo et al.
CVI 2002;9:8-18.
FULL TEXT  

Molecular Characterization of First Human Bartonella Strain Isolated in Italy
Ciervo et al.
J. Clin. Microbiol. 2001;39:4554-4557.
ABSTRACT | FULL TEXT  

Bartonella quintana and Urban Trench Fever
Ohl and Spach
Clinical Infectious Diseases 2000;31:131-135.
ABSTRACT | FULL TEXT  

Rats of the Genus Rattus are Reservoir Hosts for Pathogenic Bartonella Species: An Old World Origin for a New World Disease?
Ellis et al.
The Journal of Infectious Disease 1999;180:220-224.
ABSTRACT | FULL TEXT  

Evaluation of Human Seroreactivity to Bartonella Species in Sweden
Holmberg et al.
J. Clin. Microbiol. 1999;37:1381-1384.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.